CAS RN: 185398-21-4
2′-O-tert-butyldimethylsilyl-N4-benzoyl-cytidine
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250605 |
25mg / 100mg |
Out of stock |
15 business days | Inquiry |
GET A QUOTE
185398-21-4 / 2-trimethylsilylethyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-morpholin-4-ylbenzoate
Standard CAS: 185398-21-4
Multi CAS: No
Basic Information
CAS
185398-21-4
Multi CAS
No
Molecular Formula
C22H31N3O6Si
Molecular Weight
461.600000
Exact Mass
461.198212
SMILES
COC1=CC(=NC(=N1)OC2=CC=CC(=C2C(=O)OCC[Si](C)(C)C)N3CCOCC3)OC
InChI
InChI=1S/C22H31N3O6Si/c1-27-18-15-19(28-2)24-22(23-18)31-17-8-6-7-16(25-9-11-29-12-10-25)20(17)21(26)30-13-14-32(3,4)5/h6-8,15H,9-14H2,1-5H3
InChIKey
CNJHCNDCMCBWHV-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
32
Aromatic heavy atom count
12
Fraction Csp3
0.5
Rotatable bonds
9
H-bond acceptors
9
Molar refractivity
123.12
TPSA
92.24
LogP / Solubility
WLOGP
3.62
MLOGP
3.21
XLogP3
3.62
Consensus LogP
3.48
Log S (ESOL)
-4.66
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.96
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.74
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.97
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5